Search

Your search keyword '"Luo, Dong"' showing total 2,589 results

Search Constraints

Start Over You searched for: Author "Luo, Dong" Remove constraint Author: "Luo, Dong"
2,589 results on '"Luo, Dong"'

Search Results

1. Invisible Gas Detection: An RGB-Thermal Cross Attention Network and A New Benchmark

3. A compromised constitution of intersubjectivity from the perspective of a Weylian schema

4. Understanding and Interpretations of Quantum Mechanics

5. Bounding the FDP in competition-based control of the FDR

10. Geometric Rectification of Creased Document Images based on Isometric Mapping

11. 系统性免疫炎症指数对急性缺血性卒中后抑郁的预测价值 Predictive Value of Systemic Immune-Inflammatory Index on Post-Stroke Depression in Patients with Acute Ischemic Stroke

14. Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

15. Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

27. Three-Dimensional Force Sensor Based on Deep Learning

31. Optical manipulation of electronic dimensionality in a quantum material

32. Competition-based control of the false discovery proportion

36. Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial

37. Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial

40. A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients

41. Neoadjuvant and adjuvant toripalimab for high-risk locoregionally advanced nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled phase 2 trial.

42. Tislelizumab versus placebo combined with induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant tislelizumab or placebo for locoregionally advanced nasopharyngeal carcinoma: Interim analysis of a multicenter, randomized, placebo-controlled, double-blind, phase 3 trial.

44. Induction-concurrent versus concurrent-adjuvant chemoradiotherapy in patients with high-risk N2–3 nasopharyngeal carcinoma: An open-label, randomised, controlled, phase 3 trial.

46. Apo-Opsin and Its Dark Constitutive Activity across Retinal Cone Subtypes.

49. Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Catalog

Books, media, physical & digital resources